[1] CONRAD N, MISRA S, VERBAKEL JY, et al. Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK. Lancet. 2023;401(10391):1878-1890.
[2] MILLER FW. The increasing prevalence of autoimmunity and autoimmune diseases: an urgent call to action for improved understanding, diagnosis, treatment, and prevention. Curr Opin Immunol. 2023;80:102266.
[3] GUTIERREZ-ARCELUS M, RICH SS, RAYCHAUDHURI S. Autoimmune diseases - connecting risk alleles with molecular traits of the immune system. Nat Rev Genet. 2016;17(3):160-174.
[4] SCHERLINGER M, MERTZ P, SAGEZ F, et al. Worldwide trends in all-cause mortality of auto-immune systemic diseases between 2001 and 2014. Autoimmunity Rev. 2020;19(6):102531.
[5] ZHAO M, ZHAI H, LI H, et al. Age-standardized incidence, prevalence, and mortality rates of autoimmune diseases in adolescents and young adults (15-39 years): an analysis based on the global burden of disease study 2021. BMC Public Health. 2024;24(1):1800.
[6] SONG Y, LI J, WU Y. Evolving understanding of autoimmune mechanisms and new therapeutic strategies of autoimmune disorders. Signal Transduct Target Ther. 2024;9(1):263.
[7] ROBERTS MH, ERDEI E. Comparative United States autoimmune disease rates for 2010-2016 by sex, geographic region, and race. Autoimmun Rev. 2020;19(1):102423
[8] FANG Y, NI J, WANG YS, et al. Exosomes as biomarkers and therapeutic delivery for autoimmune diseases: Opportunities and challenges. Autoimmun Rev. 2023;22(3):103260.
[9] SHI G, ZHANG J, ZHANG ZJ, et al. Systemic Autoimmune Diseases 2014. J Immunol Res. 2015;2015:183591.
[10] VIVAS AJ, BOUMEDIENE S, TOBÓN GJ. Predicting autoimmune diseases: A comprehensive review of classic biomarkers and advances in artificial intelligence. Autoimmun Rev. 2024;23(9):103611.
[11] DHITAL R, KAVANAUGH A. Autoimmune consequences of biologics. J Allergy Clin Immunol. 2022;149(1):48-50.
[12] MCCOY MK, TANSEY MG. TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease. J Neuroinflammation. 2008;5:45.
[13] BALOGH L, OLÁH K, SÁNTA S, et al. Novel and potential future therapeutic options in systemic autoimmune diseases. Front Immunol. 2024;15:1249500.
[14] SHAH SC, ITZKOWITZ SH. Colorectal Cancer in Inflammatory Bowel Disease: Mechanisms and Management. Gastroenterology. 2022;162(3): 715-730.e3.
[15] KRUSIŃSKI A, GRZYWA-CELIŃSKA A, SZEWCZYK K, et al. Various Forms of Tuberculosis in Patients with Inflammatory Bowel Diseases Treated with Biological Agents. Int J Inflam. 2021; 2021:6284987.
[16] ROSE NR. Prediction and Prevention of Autoimmune Disease in the 21st Century: A Review and Preview. Am J Epidemiol. 2016; 183(5):403-406.
[17] BERKOVIC D, AYTON D, BRIGGS AM, et al. “The Financial Impact Is Depressing and Anxiety Inducing”: A Qualitative Exploration of the Personal Financial Toll of Arthritis. Arthritis Care Res (Hoboken). 2021;73(5):671-679.
[18] STONE R. The inflamed brain. Science. 2024; 384(6697):728-733.
[19] AL-DIWANI AAJ, POLLAK TA, IRANI SR, et al. Psychosis: an autoimmune disease? Immunology. 2017;152(3):388-401
[20] BENROS ME, MORTENSEN PB, EATON WW. Autoimmune diseases and infections as risk factors for schizophrenia. Ann N Y Acad Sci. 2012; 1262:56-66.
[21] LIU H, LIU H, TIAN B, et al. Alterations in cerebral perfusion and corresponding brain functional networks in systemic lupus erythematosus with cognitive impairment. Sci Rep. 2025;15:1310.
[22] BARRACLOUGH M, MCKIE S, PARKER B, et al. Altered cognitive function in systemic lupus erythematosus and associations with inflammation and functional and structural brain changes. Ann Rheum Dis. 2019;78(7):934-940.
[23] VALLERAND IA, PATTEN SB, BARNABE C. Depression and the risk of rheumatoid arthritis. Curr Opin Rheumatol. 2019;31(3): 279-284.
[24] FIGUEIREDO-BRAGA M, CORNABY C, CORTEZ A, et al. Influence of Biological Therapeutics, Cytokines, and Disease Activity on Depression in Rheumatoid Arthritis. J Immunol Res. 2018;2018:5954897.
[25] MARSLAND AL, KUAN DCH, SHEU LK, et al. Systemic Inflammation and Resting State Connectivity of the Default Mode Network. Brain Behav Immun. 2017;62:162-170.
[26] LIZANO P, KIELY C, MIJALKOV M, et al. Peripheral inflammatory subgroup differences in anterior Default Mode network and multiplex functional network topology are associated with cognition in psychosis. Brain Behav Immun. 2023;114:3-15.
[27] HANLY JG, ROBERTSON JW, LEGGE A, et al. Resting state functional connectivity in SLE patients and association with cognitive impairment and blood-brain barrier permeability. Rheumatology (Oxford). 2023;62(2):685-695.
[28] HANLY JG, KOZORA E, BEYEA SD, et al. Review: Nervous System Disease in Systemic Lupus Erythematosus: Current Status and Future Directions. Arthritis Rheumatol. 2019;71(1):33-42.
[29] SEKULA P, DEL GRECO MF, PATTARO C, et al. Mendelian Randomization as an Approach to Assess Causality Using Observational Data. J Am Soc Nephrol. 2016;27(11):3253-3265.
[30] TISSINK E, WERME J, LANGE S C DE, et al. The Genetic Architectures of Functional and Structural Connectivity Properties within Cerebral Resting-State Networks. eNeuro. 2023; 10(4):ENEURO.0242-22.2023.
[31] THOMAS YEO BT, KRIENEN FM, SEPULCRE J, et al. The organization of the human cerebral cortex estimated by intrinsic functional connectivity.J Neurophysiol. 2011;106(3):1125-1165.
[32] HUANG D, WU Y, YUE J, et al. Causal relationship between resting-state networks and depression: a bidirectional two-sample mendelian randomization study. BMC Psychiatry. 2024;24(1):402.
[33] CANELA-XANDRI O, RAWLIK K, TENESA A. An atlas of genetic associations in UK Biobank. Nat Genet. 2018;50(11):1593-1599.
[34] DÖNERTAŞ HM, FABIAN DK, VALENZUELA MF, et al. Common genetic associations between age-related diseases. Nat Aging. 2021;1(4):400-412.
[35] JIANG L, ZHENG Z, FANG H, et al. A generalized linear mixed model association tool for biobank-scale data. Nat Genet. 2021;53(11):1616-1621.
[36] ANDLAUER TFM, BUCK D, ANTONY G, et al. Novel multiple sclerosis susceptibility loci implicated in epigenetic regulation. Sci Adv. 2016; 2(6):e1501678.
[37] CHIA R, SAEZ-ATIENZAR S, MURPHY N, et al. Identification of genetic risk loci and prioritization of genes and pathways for myasthenia gravis: a genome-wide association study. Proc Natl Acad Sci U S A. 2022;119(5):e2108672119.
[38] GLANVILLE KP, COLEMAN JRI, O’REILLY PF, et al. Investigating Pleiotropy Between Depression and Autoimmune Diseases Using the UK Biobank. Biol Psychiatry Glob Open Sci. 2021;1(1):48-58.
[39] BURGESS S, BOWDEN J, FALL T, et al. Sensitivity Analyses for Robust Causal Inference from Mendelian Randomization Analyses with Multiple Genetic Variants. Epidemiology. 2017;28(1):30-42.
[40] BENJAMINI Y, HOCHBERG Y. Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. J R Stat Soc Series B Stat Methodol.1995;57(1): 289-300.
[41] ZHENG JF, LEE YH, LEONG PY. The Modern Epidemic of Autoimmunity. Int J Rheum Dis. 2024; 27(11):e15426.
[42] CHANG R, YEN-TING CHEN T, WANG SI, et al. Risk of autoimmune diseases in patients with COVID-19: A retrospective cohort study. EClinicalMedicine. 2023;56:101783.
[43] JOO YB, LIM YH, KIM KJ, et al. Respiratory viral infections and the risk of rheumatoid arthritis. Arthritis Res Ther. 2019;21(1):199.
[44] YIQI YAN, RUI HAN, YAOLEI MA, et al.Plant adaptive agents: promising therapeutic molecules in the treatment of post-viral fatigue. Acupunct Herb Med. 2023;3(1):20-27.
[45] QIANRU ZHAO, RONGHUA ZHAO, ZIHAN GENG, et al. Xuanfei Baidu granule alleviates coronavirus-induced pneumonia in low-temperature and high-humidity environments. Acupunct Herb Med. 2023;3(3):200-206.
[46] THORBURN AN, MACIA L, MACKAY CR. Diet, metabolites, and “western-lifestyle” inflammatory diseases. Immunity. 2014;40(6):833-842.
[47] HSIAO YH, CHEN YT, TSENG CM, et al. Sleep disorders and increased risk of autoimmune diseases in individuals without sleep apnea. Sleep. 2015;38(4):581-586.
[48] SKEVAKI C, NADEAU KC, ROTHENBERG ME, et al. Impact of climate change on immune responses and barrier defense. J Allergy Clin Immunol. 2024;153(5):1194-1205.
[49] TANG KT, TSUANG BJ, KU KC, et al. Relationship between exposure to air pollutants and development of systemic autoimmune rheumatic diseases: a nationwide population-based case-control study. Ann Rheum Dis. 2019;78(9):1288-1291.
[50] LUO B, XIANG D, JI X, et al. The anti-inflammatory effects of exercise on autoimmune diseases: A 20-year systematic review. J Sport Health Sci. 2024;13(3):353-367.
[51] CRITCHLEY HD, HARRISON NA. Visceral influences on brain and behavior. Neuron. 2013;77(4):624-638.
[52] GIANAROS PJ, WAGER TD. Brain-Body Pathways Linking Psychological Stress and Physical Health. Curr Dir Psychol Sci. 2015;24(4):313-321.
[53] EISENBERGER NI, COLE SW. Social neuroscience and health: neurophysiological mechanisms linking social ties with physical health. Nat Neurosci. 2012;15(5):669-674.
[54] DUM RP, LEVINTHAL DJ, STRICK PL. Motor, cognitive, and affective areas of the cerebral cortex influence the adrenal medulla. Proc Natl Acad Sci U S A. 2016;113(35):9922-9927.
[55] BUSHNELL MC, CEKO M, LOW LA. Cognitive and emotional control of pain and its disruption in chronic pain. Nat Rev Neurosci. 2013;14(7):502-511.
[56] BALIKI MN, GEHA PY, APKARIAN AV, et al. Beyond feeling: chronic pain hurts the brain, disrupting the default-mode network dynamics. J Neurosci. 2008;28(6):1398-1403.
[57] BASU N, KAPLAN CM, ICHESCO E, et al. Neurobiologic Features of Fibromyalgia Are Also Present Among Rheumatoid Arthritis Patients. Arthritis Rheumatol. 2018;70(7):1000-1007.
[58] SUNDERMANN B, BURGMER M, POGATZKI-ZAHN E, et al. Diagnostic classification based on functional connectivity in chronic pain: model optimization in fibromyalgia and rheumatoid arthritis. Acad Radiol. 2014;21(3):369-377.
[59] CORBETTA M, SHULMAN GL. Control of goal-directed and stimulus-driven attention in the brain. Nat Rev Neurosci. 2002;3(3):201-215.
[60] SARA SJ, BOURET S. Orienting and reorienting: the locus coeruleus mediates cognition through arousal. Neuron. 2012;76(1):130-141.
[61] BARI A, XU S, PIGNATELLI M, et al. Differential attentional control mechanisms by two distinct noradrenergic coeruleo-frontal cortical pathways. Proc Natl Acad Sci U S A. 2020;117(46):29080-29089.
[62] SZELÉNYI J, VIZI ES. The catecholamine cytokine balance: interaction between the brain and the immune system. Ann N Y Acad Sci. 2007;1113:311-324.
[63] ENGLER H, DOENLEN R, RIETHER C, et al. Chemical destruction of brain noradrenergic neurons affects splenic cytokine production. J Neuroimmunol. 2010;219(1-2):75-80.
[64] FEINSTEIN DL, KALININ S, BRAUN D. Causes, consequences, and cures for neuroinflammation mediated via the locus coeruleus: noradrenergic signaling system. J Neurochem. 2016;139(S2):154-178.
[65] LIMANAQI F, BUSCETI CL, BIAGIONI F, et al. Autophagy-Based Hypothesis on the Role of Brain Catecholamine Response During Stress. Front Psychiatry. 2020;11:569248.
[66] POPULIN L,STEBBING MJ, FURNESS JB.Neuronal regulation of the gut immune system and neuromodulation for treating inflammatory bowel disease. FASEB Bioadv. 2021;3(11):953-966.
[67] ARULCHELVAN E, VANNESTE S. Transcutaneous electrical stimulation enhances episodic memory encoding via a noradrenaline-attention network, with associated neuroinflammatory changes. Brain Stimul. 2025;18(1):191-207.
[68] WANG H, LABUS JS, GRIFFIN F, et al. Functional brain rewiring and altered cortical stability in ulcerative colitis. Mol Psychiatry. 2022;27(3):1792-1804.
[69] LEECH R, BRAGA R, SHARP DJ. Echoes of the brain within the posterior cingulate cortex. J Neurosci. 2012;32(1):215-222.
[70] LEECH R, SHARP DJ. The role of the posterior cingulate cortex in cognition and disease.Brain. 2014;137(Pt 1):12-32.
[71] HALL CV, RADFORD-SMITH G, SAVAGE E, et al. Brain signatures of chronic gut inflammation. Front Psychiatry. 2023;14:1250268.
[72] BONAZ BL, BERNSTEIN CN. Brain-gut interactions in inflammatory bowel disease. Gastroenterology. 2013;144(1):36-49.
[73] MATTEOLI G, BOECKXSTAENS GE. The vagal innervation of the gut and immune homeostasis. Gut. 2013;62(8):1214-1222.
[74] NOSEDA R, COPENHAGEN D, BURSTEIN R. Current understanding of photophobia, visual networks and headaches. Cephalalgia. 2019;39(13):1623-1634.
[75] KORNELSEN J, WITGES K, LABUS J, et al. Brain structure and function changes in ulcerative colitis. Neuroimage Rep. 2021;1(4):100064.
[76] CUNNINGHAM C. Microglia and neurodegeneration: the role of systemic inflammation. Glia. 2013;61(1):71-90.
[77] FRANK-CANNON TC, ALTO LT, MCALPINE FE, et al.Does neuroinflammation fan the flame in neurodegenerative diseases? Mol Neurodegener. 2009;4:47
[78] VENEGAS C, KUMAR S, FRANKLIN BS, et al. Microglia-derived ASC specks cross-seed amyloid-β in Alzheimer’s disease. Nature. 2017; 552(7685):355-361.
[79] NUSSLOCK R, MILLER GE. Early-Life Adversity and Physical and Emotional Health Across the Lifespan: A Neuroimmune Network Hypothesis. Biol Psychiatry. 2016;80(1):23-32.
[80] INAGAKI TK, MUSCATELL KA, IRWIN MR, et al. Inflammation selectively enhances amygdala activity to socially threatening images. Neuroimage. 2012;59(4):3222-3226.
[81] HARRISON NA, DOELLER CF, VOON V, et al. Peripheral inflammation acutely impairs human spatial memory via actions on medial temporal lobe glucose metabolism. Biol Psychiatry. 2014; 76(7):585-593.
[82] KRAYNAK TE, MARSLAND AL, WAGER TD, et al. Functional neuroanatomy of peripheral inflammatory physiology: A meta-analysis of human neuroimaging studies. Neurosci Biobehav Rev. 2018;94:76-92.
[83] WANG L, HAN K, HUANG Q, et al. Systemic lupus erythematosus-related brain abnormalities in the default mode network and the limbic system: A resting-state fMRI meta-analysis. J Affect Disord. 2024;355:190-199.
[84] BASU N, KAPLAN CM, ICHESCO E, et al. Functional and structural magnetic resonance imaging correlates of fatigue in patients with rheumatoid arthritis. Rheumatology (Oxford). 2019;58(10):1822-1830.
[85] DEMURU M, VAN DUINKERKEN E, FRASCHINI M, et al. Changes in MEG resting-state networks are related to cognitive decline in type 1 diabetes mellitus patients. Neuroimage Clin. 2014;5:69-76.
[86] CROOSU SS, HANSEN TM, BROCK B, et al. Altered functional connectivity between brain structures in adults with type 1 diabetes and polyneuropathy. Brain Res. 2022;1784:147882.
[87] GONZALEZ-ESCAMILLA G, FLEISCHER V, MONGAY-OCHOA N, et al.Dynamic reorganization of the somatomotor network in multiple sclerosis - Evidence from edge-centric functional connectivity analysis. Brain Stimul. 2024;17(5):980-982.
|